Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Non-Hodgkin 15 Neoplasm Metastasis 9 Lymphoma, Large B-Cell, Diffuse 8 Breast Neoplasms 8 Neoplasms 6 Lymphoma, Follicular 6 Lymphoma 5 Multiple Myeloma 4 Lymphoma, B-Cell, Marginal Zone 4 Leukemia, Lymphocytic, Chronic, B-Cell 4 Endometrial Neoplasms 4 Recurrence 3 Prostatic Neoplasms 3 Ovarian Neoplasms 3 Lymphoma, Mantle-Cell 3 Hodgkin Disease 3 Urinary Bladder Neoplasms 2 Thyroid Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Pancreatic Neoplasms 2 Lymphoma, T-Cell, Peripheral 2 Hematologic Neoplasms 2 Colonic Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma, Hepatocellular 2 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Ureteral Neoplasms 1 Triple Negative Breast Neoplasms 1

Interventions

Trastuzumab 4 pyrotinib 3 Vinorelbine 2 pertuzumab 1 copanlisib 1 Lapatinib 1 Docetaxel 1 Carboplatin 1 Capecitabine 1 Ado-Trastuzumab Emtansine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

HER2 Positive Breast Cancer × copanlisib × Clear all

NCT02705859 2026-04-13

Panther

Cancer Trials Ireland

Phase 1 Completed

HER2 Positive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡